Siddharth Advant, Kemwell BioPharma, USA and India

Hazel Aranha, Field Marketing Manager, Purification Technologies, Sartorius Stedim North America, Bohemia, NY, USA

R. Lee Buckler, VP Business and Corporate Development, RepliCel Life Sciences Inc., Vancouver, BC, Canada

Peter Calcott, President, Calcott Consulting LLC, Berkeley CA, USA

Yuan Chang, CMC Team Leadership, Biopharmaceutical Development, Gaithersburg, MD, USA

Michel Chartrain, Distinguished Senior Investigator, Merck and CO, Rahway, NJ, USA

John J. Dougherty, Regulatory Scientist, Eli Lilly & Company, Indianapolis, IN, USA

Jim Faulkner, Head of Manufacturing, Autolus Ltd., London, UK

Pete Gagnon, Vice President of Process Sciences, Avid Bioservices, Tustin, CA, USA

Timothy K. Hayes, Vice President and Strategic Regulatory Advisor, ProMetic BioTherapeutics Inc., League City, TX, USA

Kenneth Hughes, President, Roker Biotechnologies, Inc., Toronto, ON, Canada

Susan Dana Jones, Principal Consultant, BioProcess Technology Consultants, Acton, MA, USA

Alois Jungbauer, Professor, University of Natural Resources and Life Sciences, Vienna, Austria

Dennis M. Kraichely, Associate Director and CMC Team Leader,Johnson & Johnson Pharmaceutical R&D, Malvern, PA, USA

Blanca Lain, Protein Purification Process Development Consultant, Boston, MA, USA

Otto-Wilhelm Merten, Gene Therapy Program, Généthon II, Evry, France

Adriana E. Manzi, Managing Director, Atheln, Inc., San Diego, CA, USA

Miriam Monge, Director of Marketing for Integrated Solutions, Sartorius Stedim Biotech, Göttingen, Germany

Bryan D. Monroe, founder and primary consultant, Primus Consulting, Kingston, WA, USA

T. Shantha Raju, Senior Director of Analytical Sciences, Medimmune, Mountain View, CA, USA

Nadine M. Ritter, President and Analytical Advisor, Global Biotech Experts LLC, Alexandria, VA, USA

Sally Seaver, President, Seaver Associates LLC, Concord, MA, USA

Robert P. Shaw, Program Director, EMD Millipore, Billerica, MA, USA

Abhinav Shukla, Senior Vice President of Development and Manufacturing, KBI Biopharma, Raleigh-Durham, NC, USA

Nanda Subbarao, Senior Consultant, Biologics Consulting Group, Plainsboro, NJ, USA

Michiel Ultee, Principal Consultant, Ulteemit BioConsulting, LLC, Hillsborough, NJ, USA

Scott M. Wheelwright, Principal Consultant, Complya Asia Co.Ltd., Suzhou, China

William G. Whitford, BioProcess Strategic Solutions Leader, GE Healthcare Life Sciences, Logan UT, USA

Shuichi Yamamoto, Professor, Process Design and Engineering Laboratory, Yamaguchi University Graduate School of Medicine, Tokiwadai, Japan

Jianguo Yang, Chief Executive Officer, Abpro-China; Vice President, Abpro-US, Woburn, MA, USA

Jerry X. Yang, President, DZM Biotech Ltd., Daqing, China